Characteristics and early outcomes of children and adolescents
treated with darunavir/ritonavir-, raltegravir- or etravirine-containing
antiretroviral therapy in the Western Cape Province of South Africa.
Nuttall J, Pillay V.
S Afr Med J. 2018 Feb 1;
Abstract
Working Memory Profiles in HIV-Exposed, Uninfected and HIV-Infected Children: A
Comparison with Neurotypical Controls.
Milligan R, Cockcroft K.
Front
Hum Neurosci. 2017 Jul 6;11:348. |
Abstract
Early antiretroviral therapy reduces hiv dna following perinatal HIV infection.
Foster C, Pace M, Kaye S,
et al
l
A IDS. 2017 Jun 12.
Abstract
FULL-TEXT ARTICLE
Clinical Determinants of HIV-1B Between-Host Evolution and their
Association with Drug Resistance in Pediatric Patients.
Pagán I, Rojas P, Ramos JT, Holguín Á.
PLoS One. 2016 Dec
1;11(12):e0167383.
Paper
FULL-TEXT ARTICLE
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern
Malawi.
Brophy JC, Hawkes MT, Mwinjiwa E,
et al
PLoS One. 2016 Nov
3;11(11):e0165772.
Paper
Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children.
Luzuriaga K.
Annu Rev Med.
2016 Jan 14;67:201-13.
Abstract
Neurocognition and quality of life after reinitiating antiretroviral therapy
in children randomized to planned treatment interruption.
Ananworanich J, Melvin D, Amador JT,
et al
AIDS. 2016 Jan 4.
Abstract
FULL-TEXT ARTICLE
The last and
first frontier - emerging challenges for HIV treatment and prevention in the
first week of life with emphasis on premature and low birth weight infants.
Cotton MF, Holgate S,
Nelson A, et al
J Int AIDS Soc. 2015 Dec 2;18(7
Suppl 6):20271.
Paper
FULL-TEXT ARTICLE
Sequencing paediatric antiretroviral therapy in the context of a public
health approach.
Boerma RS, Boender TS, van Hensbroek MB,
et al
J Int AIDS Soc. 2015
Dec 2;18(7 Suppl 6):20265.
Paper
Antiretroviral Treatment and Resistance Patterns in HIV-Infected Children.
Adetokunboh O, Atibioke O, Balogun T, Oluwasanu M.
Curr Infect Dis Rep. 2015
Oct;17(10):502.
Abstract
An update on the HIV treatment cascade in children and adolescents.
Bobat R, Archary M, Lawler M.
Curr Opin HIV AIDS.
2015 Sep 8
Abstract
Early diagnosis is critical to ensure good outcomes in
HIV-infected children: outlining barriers to care.
Feucht UD, Meyer A, Thomas WN,
et al
AIDS Care.
2015 Aug 14:1-11
Abstract
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity
in HIV-Infected Infants Is Associated with Reduced Mortality.
Milligan C, Richardson BA, John-Stewart G, et al
Cell Host Microbe. 2015 Apr 8;17(4):500-506.
Abstract
Incomplete immune reconstitution despite virologic
suppression in HIV-1 infected children and adolescents.
Krogstad P, Patel K,
Karalius B,. et al
AIDS. 2015 Mar 27;29(6):683-693
Abstract
Rapid Viral Rebound After 4 Years of Suppressive Therapy in a
Seronegative HIV-1 Infected Infant Treated From Birth.
Butler KM, Gavin P, Coughlan S,
et al
Pediatr Infect Dis J. 2015
Mar;34(3):e48-e51.
Abstract
Viremic Relapse after HIV-1 Remission in a Perinatally
Infected Child.
Luzuriaga K, Gay H,
Ziemniak C, et al
N Engl J Med. 2015 Feb
19;372(8):786-788.
Abstract
Prevention of mother-to-child transmission of HIV Type
1: the role of neonatal and infant prophylaxis.
Hurst SA, Appelgren
KE, Kourtis AP.
Expert
Rev Anti Infect Ther. 2015 Feb;13(2):169-81
Abstract
Paediatric European Network for Treatment of AIDS (PENTA)
guidelines for treatment of paediatric HIV-1 infection 2015: optimizing
health in preparation for adult life.
Bamford A, Turkova A, Lyall H, et
al
HIV Med. 2015 Feb 3.
Abstract
Palliative care needs of HIV exposed and infected children admitted to the
inpatient paediatric unit in Uganda.
Nakawesi J, Kasirye I, Kavuma D, et al
Ecancermedicalscience. 2014 Dec
11;8:489.
Abstract
Pediatric HIV Long-Term Nonprogressors.
Rimawi BH, Rimawi RH, Micallef M,
Case Rep Infect Dis. 2014;2014:752312
Abstract
Predicting long-term outcomes for children affected by HIV
and AIDS: perspectives from the scientific study of children's development.
Stein A, Desmond C,
Garbarino J, et al
AIDS.
2014 Jul;28 Suppl 3:S261-8.
Abstract
Weight as predictors of clinical progression and treatment
failure: Results from the TREAT Asia Pediatric HIV
Observational Database (TApHOD).
Kariminia A, Durier N, Jourdain G, Saghayam S, et al
J Acquir Immune Defic Syndr.
2014 May 27.
Abstract
The role of albuminuria in the follow-up of HIV-infected pediatric patients.
Deyà-Martínez A, Noguera-Julian A, et al
Pediatr Nephrol. 2014 Apr
16
Abstract
Optimization of antiretroviral therapy in HIV-infected children under 3
years of age: a systematic review.
Penazzato M, Prendergast AJ, Muhe LM,
AIDS. 2014 Mar;28 Suppl
2:S137-46
Abstract
Pediatric treatment 2.0: ensuring a holistic response to caring
for HIV-exposed and infected children.
Essajee SM, Arpadi SM, Dziuban
EJ, et al
AIDS.
2013 Nov;27 Suppl 2:S215-24.
Abstract
Clinically significant interactions between antiretroviral and
co-prescribed drugs for HIV-infected children: profiling and comparison of two
drug databases.
Oshikoya KA, Oreagba IA, Ogunleye OO,
et al
Ther Clin Risk Manag.
2013;9:215-221
Abstract
Performance of Clinical Criteria for Screening of Possible
Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra.
Langs-Barlow A, Renner L,
AIDS Res Treat. 2013;2013:249171
Abstract
Complications of long-term antiretroviral therapy
in HIV-infected children.
Prendergast AJ.
Arch Dis Child. 2013 Feb 14.
Abstract |